Pfizer, U.S. ink $5.29B deal for possible COVID-19 treatment

11/18/2021 | by | Uncategorized

The deal will net the U.S. 10 million treatment courses.
Source: Test feed

Leave a Comment

Your email address will not be published.

*
*
*